Early Nutrition and Neurological Development of Very Preterm Infants
NCT ID: NCT01486173
Last Updated: 2013-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
260 participants
OBSERVATIONAL
2011-06-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* the quantity of mother's milk and duration of breastfeeding
* the intake of polyunsaturated fatty acids and iron during hospitalization and the development of preterm infants born with a GA \< 32 weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Physical Treatments of Human Milk on the Kinetics of Gastric Lipolysis in Preterm Newborns
NCT02112331
Effect of Infant Formula Intake on Infant Growth From 0 to 6 Months.
NCT02997826
Effect of Intake in Bioactive Molecules From Natural or Pasteurised Milk on Gut Maturation in Very Premature Newborns
NCT01177475
Protein Balance and Body Composition in Preterm Infants
NCT03013374
Food Habit Programming: Influence of Genetics and Early Nutrition in a Population of Preterm Infants
NCT00663572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premature infants with a GA < 32 Weeks
No interventions assigned to this group
New born with a GA > 37Weeks
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* agreement of parents
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lapillonne, Alexandre, M.D.
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexandre Lapillonne, M.D., Ph.D.
Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandre Lapillonne, M.D., Ph.D.
Role: STUDY_DIRECTOR
Alexandre Lapillonne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Necker hospital
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-mars-12551
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.